Blood News and Research

RSS

What's needed to protect the heart during such operations?

It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.

27 Nov 2007

MRSA in the community: A new threat to children's health?

Although hospital superbugs like MRSA - methicillin resistant Staphylococcus aureus - are now a widespread and recognised problem, new MRSA strains that have emerged and are spreading amongst the wider public in the USA may pose a bigger threat, according to Exeter researchers speaking (Wednesday 28 November 2007) at the Federation of Infection Societies Conference 2007 at the University of Cardiff, UK, which runs from 28-30 November 2007.

27 Nov 2007

Brain stem-cell therapies more complicated than thought

An MIT research team's latest finding suggests that stem cell therapies for the brain could be much more complicated than previously thought.

27 Nov 2007

Discovery of key acute myeloid leukemia gene

A gene called N-Myc leads a double life in certain white blood cells, helping to trigger a cancer called acute myeloid leukemia (AML) under some conditions while triggering apoptosis, or cell suicide, under other conditions, according to results of a mouse study done by investigators at St. Jude Children's Research Hospital.

27 Nov 2007

Ikaria's INOmax approved in Australia

Ikaria Holdings, Inc., through its subsidiary INO Therapeutics LLC, announced today that it has received approval from Australia's regulatory body, the Therapeutic Goods Administration (TGA), for INOmax (nitric oxide) for inhalation.

27 Nov 2007

Alcohol and tobacco use doesn't boost HPV-related cancer risk

Heavy smoking and drinking are known to cause head and neck cancer. Infection with human papillomavirus type 16 (HPV16), a common strain of the sexually-transmitted HPV virus, is another known risk factor for head and neck cancer, which affects about 500,000 people each year worldwide.

27 Nov 2007

Blood-vessel blocker aids cancer-killing virus

Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly move in and eliminate them.

27 Nov 2007

BioMarin files investigational NDA for PEG-PAL for the treatment of phenylketonuria

BioMarin Pharmaceutical Inc. has announced that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for PEG-PAL (Poly Ethylene Glycol-Phenylalanine Ammonia Lyase), formerly known as Phenylase, for the treatment of phenylketonuria (PKU).

27 Nov 2007

Atrial fibrillation screening can identify irregular heartbeat that leads to stroke

A simple screening can identify atrial fibrillation, such as that discovered yesterday in Vice-President Dick Cheney, and can do so even if the person is unaware of the presence of this irregular heart rhythm.

27 Nov 2007

Gastric bypass complications

Obese patients who suffer complications after gastric bypass surgery may face further health risks because their weight exceeds the limits of diagnostic imaging equipment, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).

27 Nov 2007

Alcohol may promote scarring and airway injury after transplantation

A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.

27 Nov 2007

Red blood cell transfusions under scrutiny - research reveals potential harm

Bristol scientists have found that red blood cell transfusions given to people having heart surgery could increase the risk of heart attack or stroke.

27 Nov 2007

Pregnant women may be having too many high-tech scans

A new study has found that pregnant women are having more high-tech imaging examinations and are thereby exposing their babies to higher doses of radiation than a decade ago.

27 Nov 2007

FDA takes on board the salt issue

The Food and Drug Administration (FDA) in the United States has announced a public hearing on its policies regarding salt and sodium in food.

27 Nov 2007

Wyeth receives European approval for TORISEL

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the European Commission has approved TORISEL (temsirolimus) for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL is the only approved cancer therapy that specifically inhibits the mTOR (mammalian target of rapamycin) kinase, an important regulator of cell proliferation, cell growth and cell survival.

27 Nov 2007

Researchers transfer immune response to myeloma patient

Researchers at the University of Arkansas for Medical Sciences (UAMS) have for the first time transferred an immune response in a healthy individual to a patient with multiple myeloma, a cancer of the bone marrow, showing promise for cancer vaccination.

27 Nov 2007

Study of Mexican Americans shows that polymorphisms of the CYP2E1 gene enhance susceptibility to alcoholism

Mexican Americans make up 66 percent of the U.S. Hispanic population and, when compared to other ethnic groups, show high rates of heavy drinking and alcohol-related problems.

27 Nov 2007

Communication key to tackling cardiovascular disease

Despite the increasing evidence that managing high cholesterol reduces cardiovascular events, many people do not achieve recommended lipid levels.

27 Nov 2007

High-glycemic index carbs linked to greater type 2 diabetes risk in Chinese and African-American women

Eating foods high on the glycemic index, which measures the effect of carbohydrates on blood glucose levels, may be associated with the risk for developing type 2 diabetes in Chinese women and in African-American women, according to two studies in the November 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Nov 2007

Less drugs may be best for treating malaria

The current dosage of drugs used in treating malaria may be helping the parasites become resistant to the drugs faster, without improving the long-term outcome in patients.

27 Nov 2007